Net profit of Bliss GVS Pharma declined 42.66% to Rs 24.26 crore in the quarter ended September 2024 as against Rs 42.31 crore during the previous quarter ended September 2023. Sales rose 2.74% to Rs 217.68 crore in the quarter ended September 2024 as against Rs 211.88 crore during the previous quarter ended September 2023. ParticularsQuarter EndedSep. 2024Sep. 2023% Var. Sales217.68211.88 3 OPM %19.0525.66 - PBDT42.6965.52 -35 PBT35.7159.13 -40 NP24.2642.31 -43 Powered by Capital Market - Live News

Bliss GVS Pharma will hold a meeting of the Board of Directors of the Company on 24 October 2024.Powered by Capital Market - Live News

Bliss GVS Pharma has allotted 157,550 equity shares under ESOP on 04 October 2024. With this allotment, the paid up equity share capital has increased to 10,53,02,022 equity shares of Re. 1/- each aggregating Rs. 10,53,02,022/-. Powered by Capital Market - Live News

Bliss GVS Pharma will hold a meeting of the Board of Directors of the Company on 24 July 2024.Powered by Capital Market - Live News

Bliss GVS Pharma announced that the 39th Annual General Meeting(AGM) of the company will be held on 25 July 2024.Powered by Capital Market - Live News